🩻 “Fischer Medical: The ₹5,000 Cr Lab Chemical Co with a 4,000+ PE and 1% ROE… What Are We Smoking?”

1. At a Glance

Fischer Medical Ventures Ltd is a ₹5,032 Cr smallcap in the medical equipment & healthcare tech space. It recently pivoted from being a sleepy chemicals trader to launching India’s first indigenous MRI systems and AI-based diagnostics. While growth is exciting, financials are, well, more fiction than fact. P/E of 4,193? Oof.

2. Intro with Hook

Let’s say you went to a diagnostic center. They scanned your body with an MRI machine made in India, powered by AI. Then you discovered the company behind it has:

• ROE of 0.57%
• OPM of 3%
• Capitalized interest? Probably.
• P/E of 4,193 🤯

And yet — the stock ran up 150% in 3 years. Welcome to Fischer Medical Ventures. A story where the pitch deck grew faster than the profits.

3. WTF Do They Even Do? (Business Model)

Originally known as Fischer Chemic, this company sold lab chemicals and dabbled in machine trading. But over the past 2 years, it morphed into:

• 🧠 AI-driven healthcare tech (FlynnCare subsidiary)
• 🧲 MRI machine manufacturing (licensed by CDSCO)
• 🌍 Strategic global expansion (Jember, Singapore, Malacca)

Business Segments Now:

• Diagnostic Equipments (MRI, AI X-ray TB Screening)
• Healthcare AI Platforms (FlynnCare)
• Chemicals & Lab Supplies (legacy)

Buzzwords per minute? 14. Actual revenue from MRI AI business? Still… developing.

4. Financials Overview: Profit, Margins, ROE, Growth

Let’s talk numbers: